 |
Mr. Rick Holliday-Smith
BA (Hons), FAICD
Appointed Chairman 1 July 2010
Appointed director 1 March 2005
Director of Servcorp Limited since 1999 and ASX Limited since 2006. Chairman of Snowy Hydro Limited (not publicly listed) since 2006. Chairman of SFE Corporation Limited since 1999 until de-listing in 2006. Former director of St George Bank Limited (2007 - 2008), Exco Resources NL (1999 - 2006), DCA Group Limited (2004 - 2006) and MIA Group Limited (2000 - 2004). Former President of NationsBank-CRT, Chicago and Managing Director of Hong Kong Bank Limited, London.
Chairman of the Nominations Committee and Technology and Innovation Committee. Member of the Audit Committee and Remuneration Committee.
|
 |
Dr. Chris Roberts
CEO/President
BE (Hons), MBA, PhD, Hon DSc (Macq), FAICD, FTSE, FIEAust
Appointed 1 February 2004
Chief Executive Officer/President of Cochlear Limited. Director of ResMed Inc since 1992 and Chairman of Research Australia (2004 - 2010). Dr Roberts has worked in the medical device industry for more than 35 years in a number of senior management positions.
Member of the Medical Science Committee and Technology and Innovation Committee.
|
 |
Mr. Paul R Bell
BA, MA (Hons)
Appointed 1 August 2005
Director of Biota Holdings Limited since 2006. Former director of Bio-Link Partners Limited (2005 – 2009) and GroPep Limited (2003 – 2006). Extensive executive career spanning 30 years with the international pharmaceutical company, Merck & Co Inc (Managing Director – Australia, 1988 – 1997; President of the Asia Pacific Human Health Division, 1997– 2002).
Chairman of the Remuneration Committee. Member of the Nominations Committee and Technology and Innovation Committee.
|
 |
Prof Edward Byrne, AO
DSc, MD, MBA, FRCP, FRACP
Appointed 1 July 2002
Vice Chancellor of Monash University. Board member of Neurosciences Victoria Limited. Former executive Dean of the Faculty of Biomedical Sciences, Vice Provost and Head of the Medical School at University College, London. Former Dean of Faculty of Medicine, Nursing and Health Sciences at Monash University, Melbourne (2003– 2006). Former director of BUPA, Neurosciences Australia Limited, the Baker Medical Research Institute, Burnet Medical Research Institute, Prince Henry’s Medical Research Institute, Southern Health, and Mental Health Research Institute.
Chairman of the Medical Science Committee. Member of the Nominations Committee and Technology and Innovation Committee.
|
 |
Mr. Andrew Denver
BSc (Hons) MBA, FAICD
Appointed 1 February 2007
Chairman of Universal Biosensor Pty Limited since 2005 (director since 2002). Director of CathRx Limited and Principals Cornerstone Management Pty Limited (not publicly listed). Former Managing Director of Memtec Limited and President Asia for Pall Corporation.
Member of the Audit Committee. Member of the Nominations Committee, Remuneration Committee and Technology and Innovation Committee.
|
 |
Mr. Donal P O'Dwyer
BE Civil, MBA
Appointed 1 August 2005
Chairman of Atcor Medical since 2004 and a director of Sunshine Heart Inc since 2004, Mesoblast Limited since 2004 and Angioblast Systems Inc since 2005. Former President of Cordis Cardiology (Johnson & Johnson medical device business unit) between 2000 and 2004.
Member of the Audit Committee, Medical Science Committee, Nominations Committee, Remuneration Committee and Technology and Innovation Committee.
|
 |
Mrs Yasmin Allen
BCom, FAICD
Appointed 2 August 2010
Director of Insurance Australia Group (IAG) since 2004, member of IAG Audit Committee and Chair of IAG Nomination and Remuneration Committee. Chair of Macquarie Specialised Asset Management (not publicly listed) since 2003. Former non-executive director of Film Australia (2004 – 2008) and Export, Finance & Insurance Corporation (2001 – 2007) and Australian Red Cross Blood Service (2002 – 2005). Former Vice President of Deutsche Bank AG, Director of ANZ Investment Bank and Associate Director, HSBC, London.
Chairperson of the Audit Committee. Member of the Nominations Committee and Technology and Innovation Committee.
|